Results 291 to 300 of about 1,237,427 (393)

Clinical significance of serum calcium-phosphorus product, parathyroid hormone, vitamin K2 in chronic kidney disease patients with coronary artery calcification. [PDF]

Ren Fail
Chen C, Chen T, Xu Y.
europepmc   +1 more source

Alcohol and the endocrine system: A critical review of disruptions, potential mechanisms, and health implications

Alcohol, Clinical and Experimental Research, Volume 50, Issue 1, January 2026.
The endocrine system coordinates whole body cellular function and maintains homeostasis. Alcohol impacts the integrity of endocrine regulation at multiple sites, contributing to risk for comorbidities. Some of the alcohol‐mediated pathophysiological effects on the endocrine system include alterations in receptor expression and responsiveness, protein ...
Patricia E. Molina, Liz Simon
wiley   +1 more source

Pre-transplant parathyroid hormone serum levels as predictors of kidney function after one year: a retrospective cohort study. [PDF]

Einstein (Sao Paulo)
Soler LM, Valiatti MF, Contti MM, Nga HS, Porto CDCS, Alencar JCG, Andrade LGM.   +6 more
europepmc   +1 more source

Hyperparathyroidism after kidney homotransplantation [PDF]

, 1987
Geis, WP, Hammond, WS, Huffer, WE, Popovtzer, MM, Starzl, TE   +4 more
core  

Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 11-23, January 2026.
Abstract Despite 2 h of daily exercise training, muscle wasting and bone loss are still present after 6‐month missions to the international space station. Some crew members lose bone much faster than others. In preparation for missions to the Moon and Mars, space agencies are therefore reviewing their countermeasure portfolios.
Friederike Thomasius, Dominik Pesta, Jörn Rittweger   +2 more
wiley   +1 more source

Is Parathyroid Hormone (PTH) Replacement Therapy Effective In Treating Patients with Hypoparathyroidism

, 2016
Kaidden G Kelly
openalex   +1 more source

Development and Validation of a Prognostic Model for Persistent Hypoparathyroidism After Total or Completion Thyroidectomy

Clinical Otolaryngology, Volume 51, Issue 1, Page 111-120, January 2026.
ABSTRACT Background The aim of this study was to develop and validate a clinical prediction model to predict the occurrence of persistent hypoparathyroidism after total or completion thyroidectomy. Methods This multicentre retrospective cohort study included patients who underwent total or completion thyroidectomy between January 2010 and June 2021 in ...
Sam P. J. van Dijk, Carolien C. H. M. Maas, Ali Alshangi, M. H. Elise van Driel, Eline A. Feitsma, Caroline M. J. van Kinschot, Ivona Lončar, Charlotte van Noord, Linetta B. Koppert, Schelto Kruijff, David van Klaveren, Cornelis Verhoef, Robin P. Peeters, Tessa M. van Ginhoven, The Hypoparathyroidism Study Group of the Thyroid Network, Kees van den Berge, Michel P. Brugts, Matthijs J. Faber, Richard P.R. Groenendijk, Saskia M.T.H. ten Have, Sigridur Jakobsdóttir, Marlies E. Kevenaar, Joke van der Linden, Elske T Massolt, Erik M. von Meyenfeldt, Charles C. van Rossem, Ellen van Schaik, Casper Smit, Maarten Staarink, Hans F. Zengerink   +29 more
wiley   +1 more source

Parathyroid Hormone Fluctuations During Thyroid and Parathyroid Surgery. [PDF]

OTO Open
Sagalow ES, Kim Y, Wong S, Wang RC.
europepmc   +1 more source

Pharmacotherapy Risks in Rare Genetic Diseases: Cross‐Referencing ACMG Secondary Findings v3.2 List With Clinical Databases

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Clinical genomics and pharmacogenomics have largely remained separate fields, though some genetic variants have overlapping disease risk and drug implications. However, the extent of this overlap is not well studied. To explore this gap, we cross‐referenced genes from the American College of Medical Genetics Secondary Findings v3.2 list with ...
Josiah D. Allen, Benjamin Q. Duong, Jordan Brady, Pamela Arn   +3 more
wiley   +1 more source

Compliance With Parathyroid Hormone Analog Medications at a Single Osteoporosis Treatment Center. [PDF]

Cureus
Johnson AH, Brennan JC, Boudani D, Chapa L, Kidd G, Turcotte JJ, Morganti C.   +6 more
europepmc   +1 more source